Li‐Tong Lin, Cheng‐Hsien Hung. Letter: Calendar Era or Antiviral Choice—What Explains the Survival Benefit of Tenofovir Disoproxil Fumarate After Hepatocellular Carcinoma Resection?. // Alimentary Pharmacology and Therapeutics. – 2026. – DOI: 10.1111/apt.70913. – URL: https://onlinelibrary.wiley.com/doi/10.1111/apt.70913?af=R
Li‐Tong Lin & Cheng‐Hsien Hung (2026). Letter: Calendar Era or Antiviral Choice—What Explains the Survival Benefit of Tenofovir Disoproxil Fumarate After Hepatocellular Carcinoma Resection?. Alimentary Pharmacology and Therapeutics. https://doi.org/10.1111/apt.70913
Li‐Tong Lin and Cheng‐Hsien Hung. “Letter: Calendar Era or Antiviral Choice—What Explains the Survival Benefit of Tenofovir Disoproxil Fumarate After Hepatocellular Carcinoma Resection?.” Alimentary Pharmacology and Therapeutics, 2026. doi:10.1111/apt.70913.
@article{Lin2026,
title = {Letter: Calendar Era or Antiviral Choice—What Explains the Survival Benefit of Tenofovir Disoproxil Fumarate After Hepatocellular Carcinoma Resection?},
author = {Lin, Li‐Tong and Hung, Cheng‐Hsien},
journal = {Alimentary Pharmacology and Therapeutics},
year = {2026},
doi = {10.1111/apt.70913},
url = {https://onlinelibrary.wiley.com/doi/10.1111/apt.70913?af=R}
}